Cardiology
Targeting specific gut bacteria and their metabolites could offer new ways to prevent or treat cardiovascular disease linked to diet and gut health.
Nicola Segata, from University of Trento, investigates the intricate links between diet, microbiome composition, and cardiometabolic outcomes.
The findings of a recent study shed light on how the microbiota impacts cholesterol levels. They may also inform microbial-based interventions against high cholesterol.
The findings of a recent study suggest that 2MBC exacerbates the susceptibility to thrombosis and may explain why people with COVID-19 are at increased thrombotic risk.
The findings show that statin-induced high blood sugar levels are associated with Clostridium bacteria and bile acids. The work also suggests that ursodiol may help reduce the adverse effects of…
A recent study poses the basis for the use of microbiome profile in AF risk prediction.
A recent study provides evidence for the beneficial effects of GMD and the gut commensal bacterium P. merdae against obesity-related atherosclerosis.
The findings of a new study suggest that Bacteroides can metabolize cholesterol, thus helping to regulate its levels in the blood.
Researchers have identified 10 species whose abundance was linked to blood levels of TMAO, a metabolite associated with cardiovascular diseases
Researchers uncover the gut microbiota changes that happen in the very early stages of heart disease. The microbial and metabolic profiles identified could be used as markers of the transition…
